Journal Information
Vol. 95. Issue 2.
Pages 252-254 (01 March 2020)
Visits
...
Vol. 95. Issue 2.
Pages 252-254 (01 March 2020)
Research Letter
Open Access
Analysis of clinical aspects of leprosy patients between 2010–2017 at a reference center in Campinas
Visits
...
Marcel Alex Soares dos Santosa,
Corresponding author
marceldossantos@yahoo.com

Corresponding author.
, José Luis Braga de Aquinob, Elisangela Pegasc, Elaine Cristina Faria Abrahao Machadod
a Department of Dermatology, Faculdade São Leopoldo Mandic de Campinas, Campinas, SP, Brazil
b Department of Head, Neck and Chest Surgery, Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil
c Leprosy, Bullous and Phototherapy Clinic, Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil
d Dermatology Clinic, Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (3)
Table 1. Comparison between operational classifications groups (Chi-square test).
Table 2. Comparison of the age of diagnosis among the variables.
Table 3. Comparison between groups of neural symptoms (Chi-square test).
Show moreShow less
Full Text
Dear Editor,

Leprosy is a contagious, chronic, granulomatous disease caused by the gram-positive bacillus Mycobacterium leprae.1

It mainly affects the skin and the peripheral nerves, but it can also compromise other organs. May have neurological and motor sequelae and have high disabling power if not treated early.2

It is still a serious public health problem and is culturally and socially linked to a stigmatizing condition. It is the main infectious cause of disability in man. In 2017, 210,671 new cases were detected in the world, Brazil being the 2nd country in the world with the highest prevalence of the disease. In 2017, the country recorded 26,875 new cases of leprosy, representing 12.7% of the global total of new occurrences.2,3

Knowing the context of leprosy patients in a university hospital, with reference service in the treatment of the disease, contributes to the formulation of strategies in public health aimed at their control and gives subsidy to actions to face this local grievance.

This is an epidemiological, descriptive, retrospective study whose objective is to analyze the relationship of the clinical variables of leprosy in the patients reported in an outpatient dermatology clinic reference in leprosy in the city of Campinas in the period of 2010–2017, by analyzing the information contained in the medical records of these patients (n=111).

The relationship between the variables was assessed using the Chi-Square test, Student's t-test or ANOVA followed by Tukey's multiple comparison test. The significance level considered was 5%.

In table 1 it is possible to see the relation of the operational classification with the other variables. Significant association of the presence of neural symptoms with operational classification (p<0.0001) was observed. There are more patients in the multibacillary classification with neural symptoms (p<0.0001), as well as physical incapacity (p=0.0124).

Table 1.

Comparison between operational classifications groups (Chi-square test).

Variable  Category  Operational classificationTotalp-Value 
    MBPBn   
    n  n       
Gender  Female  37  43.5  10  38.5  47  42.3  0.6472 
  Male  48  56.5  16  61.5  64  57.7   
Clinical form  Boderline  35  41.2  0.0  35  31.5  <0.0001 
  Indeterminate  4.7  34.6  13  11.7   
  Pure neural  3.5  3.8  3.6   
  Tuberculoid  3.5  16  61.5  19  17.1   
  Lepromatous  40  47.1  0.0  40  36.0   
Neural symptoms  No  8.8  12  46.2  19  17.9  <0.0001 
  Yes  73  91.3  14  53.8  87  82.1   
Physical disability  No  20  37.0  11  73.3  31  44.9  0.0124 
  Yes  34  63.0  26.7  38  55.1   

In the analysis of the clinical form with the other variables, it was observed an association of the clinical form with presence of neural symptoms (p=0.0002), patients with the virchowian form and dimorphic have more neural symptoms.

Table 2 shows the comparison of the age of diagnosis and the other variables studied. There was a significant difference in the age of diagnosis in relation to the operational classification (p=0.0001), patients with paucibacillary classification had a lower age of diagnosis. Patients with clinical virchowian form (p=0.0112), those with neural symptoms (p=0.0278) and with physical disability (p=0.0102) present a higher age of diagnosis.

Table 2.

Comparison of the age of diagnosis among the variables.

Variable  Category  n  Average  SD  Minimum  Median  Maximum  p-Value 
Operational classification  Multibacillary  85  50.3  16.4  15.0  51.0  87.0  0.0001 
  Paucibacillary  26  35.7  16.1  8.0  29.5  74.0   
Clinical form  Boderline  35  50.5  14.7  21.0  49.0  81.0  0.0112 
  Indeterminate  13  33.5  15.3  10.0  27.0  61.0   
  Pure neural  41.5  34.9  8.0  41.5  75.0   
  Tuberculoid  19  42.7  14.3  25.0  42.0  74.0   
  Lepromatous  40  50.6  17.5  15.0  51.5  87.0   
Neural symptoms  No  19  38.3  13.6  10.0  42.0  61.0  0.0278 
  Yes  87  47.7  17.2  8.0  48.0  81.0   
Physical disability  No  31  40.3  16.5  8.0  40.0  70.0  0.0102 
  Yes  38  50.4  15.2  18.0  51.0  79.0   
Baciloscopy pre treatment  Negative  72  46.7  17.6  8.0  45.5  81.0  0.8392 
  Positive  39  47.4  17.1  15.0  48.0  87.0   
Baciloscopy after treatment  Negative  83  46.8  16.5  8.0  48.0  78.0  0.4167 
  Positive  42.1  16.4  27.0  38.0  79.0   

Table 3 shows the associations of neural symptoms with the other variables. Patients with neural symptoms have more physical disability (p=0.0159), have more positive bacilloscopy before treatment (p=0.0139), use more frequent PQT-MB therapeutic scheme (p<0.0001) and extend the treatment more than the predetermined time (p=0.0172).

Table 3.

Comparison between groups of neural symptoms (Chi-square test).

Variable  Category  Neural symptomsTotalp-Value 
    Non   
    n  n       
Gender  Female  10  52.6  34  39.1  44  41.5  0.2775 
  Male  47.4  53  60.9  62  58.5   
Physical disability  No  80.0  23  39.0  31  44.9  0.0159 
  Yes  20.0  36  61.0  38  55.1   
Baciloscopy pretreatment  Negative  17  89.5  52  59.8  69  65.1  0.0139 
  Positive  10.5  35  40.2  37  34.9   
Baciloscopy after treatment  Negative  17  100.0  64  87.7  81  90.0  0.1270 
  Positive  0.0  12.3  10.0   
Treatment  PQT-MB  36.8  74  85.1  81  76.4  <0.0001 
  PQT-PB  12  63.2  13  14.9  25  23.6   
Extended treatment  No  16  94.1  54  65.1  70  70.0  0.0172 
  Yes  5.9  29  34.9  30  30.0   

In relation to the presence of physical disability, it was observed that male patients have more physical disability (p-value=0.0273), as well as patients with multibacillary treatment regimen (p-value=0.0046).

Multibacillary patients are twice as likely to have physical disabilities as paucibacillary patients because multibacillary patients have a high bacillary load in the body and because they have a generally more clinical picture, the bacilli act longer on the nerves, causing neural symptoms and leading to the disabilities.4

The virchowian clinical form has the greatest impact on the development of physical disabilities and deformities, increasing the chance of developing Grade II disability in 16.5 times.2

Patients older than 60 years are twice as likely to be multibacillary as young people are less exposed to Mycobacterium leprae and the development of the multibacillary form requires a long incubation period of the bacillus. Elderly patients present age-related immunological changes and increased susceptibility to infections with monocytes and neutrophils with impairment of functions, reduction of phagocytic capacity, decreased antigen presentation and change in the cytokine profile of Th1 to Th2.5

Men are 1.4 times more likely to develop physical disabilities than women because they take less health care, delaying the diagnosis and treatment of the disease. With more time of the bacillus acting actively in the organism, the greater the neural damage.2,5

The study presented some limitations. Although the dermatology outpatient clinic of the study met a wide demand in the city of Campinas-SP, only the patients notified at the site were included in the study. A large percentage of patients were not evaluated for the presence of physical disabilities (37.8%). The study was based on the classification of Madrid and the operational one presented by the WHO. It is worth noting that, unlike Ridley and Jopling's classification, the classifications used do not separate the dimorphic patients into DT, DD and DV, which present clinical, bacteriological and immunological differences.

Financial support

None declared.

Authors’ contributions

Marcel Alex Soares dos Santos: Statistic analysis; approval of the final version of the manuscript; conception and planning of the study; elaboration and writing of the manuscript; obtaining, analysis, and interpretation of the data; critical review of the literature; critical review of the manuscript.

José Luis Braga de Aquino: Approval of the final version of the manuscript; conception and planning of the study; effective participation in research orientation.

Elisangela Pegas: Conception and planning of the study; intellectual participation in the propaedeutic and/or therapeutic conduct of the studied cases.

Elaine Cristina Faria Abrahao Machado: Conception and planning of the study; elaboration and writing of the manuscript.

Conflicts of interest

None declared.

References
[1]
M.E.G.C. Silva, C.D.F. Souza, S.P.C. Silva, F.M. Costa, R.F. Carmo.
Epidemiological aspects of leprosy in Juazeiro-BA, from 2002 to 2012.
An Bras Dermatol, 90 (2015), pp. 799-805
[2]
C. Moschioni, C.M.F. Antunes, M.A.F. Grossi, J.R. Lambertucci.
Risk factors for physical disability at diagnosis of 19,283 new cases of leprosy.
Ver Soc Bras Med Trop, 43 (2010), pp. 19-22
[3]
Sinan SVS MS. [Internet].
Indicadores epidemiológicos e operacionais de hanseníase Brasil 2001–2017.
(2018),
[4]
E.M.F. Santana, K.K.G. Brito, E.M.V. Antas, J.A. Nogueira, O.D.C.P. Leadebal, M.A. Silva, et al.
Factors associated with the development of physical disabilities in Hansen's disease.
Rev Inst Med trop S Paulo, 60 (2018), pp. 27
[5]
M.L. Nobre, X. Illarramendi, K.M. Dupnik, M.A. Hacker, J.A. Nery, S.M. Jerônimo, et al.
Multibacillary leprosy by population groups in Brazil: lessons from an observational study.
PLoS Negl Trop Dis, 11 (2017), pp. e0005364

How to cite this article: Santos MAS, Aquino JLB, Pegas E, Abrahao Machado ECF. Analysis of clinical aspects of leprosy patients between 2010–2017 at a reference center in Campinas. An Bras Dermatol. 2020;95:252–4.

Study conducted at the Dermatology Clinic, Pontifícia Universidade Católica de Campinas, Campinas, SP, Brazil.

Copyright © 2020. Sociedade Brasileira de Dermatologia
Idiomas
Anais Brasileiros de Dermatologia

Subscribe to our newsletter

Article options
Tools
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.